Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease

被引：0
|
作者：
Collen, Lauren, V [1 ,2 ,3 ]
Snapper, Scott B. [1 ,2 ]
机构：
[1] Boston Childrens Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] 300 Longwood Ave,Enders 676, Boston, MA 02115 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷 / 03期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1093/ibd/izad317
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：513 / 514
页数：2
相关论文
共 50 条
  • [1] Failure Rate of Anti-Tumor Necrosis Factor α Biologics in Very Early Onset Inflammatory Bowel Disease
    Watson, Ashleigh
    Karam, Lina B.
    Kellermayer, Richard
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 510 - 512
  • [2] Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America
    Kerur, Basavaraj
    Fiedler, Karoline
    Stahl, Marisa
    Hyams, Jeffrey
    Stephens, Michael
    Lu, Ying
    Pfefferkorn, Marian
    Alkhouri, Raza
    Strople, Jennifer
    Kelsen, Judith
    Siebold, Leah
    Goyal, Alka
    Rosh, Joel R.
    LeLeiko, Neal
    Van Limbergen, Johan
    Guerrerio, Anthony L.
    Maltz, Ross M.
    Karam, Lina
    Crowley, Eileen
    Griffiths, Anne M.
    Heyman, Melvin B.
    Deneau, Mark
    Benkov, Keith
    Noe, Joshua
    Moulton, Dedrick
    Pappa, Helen
    Galanko, Joseph
    Snapper, Scott
    Muise, Aleixo M.
    Kappelman, Michael D.
    Benchimol, Eric, I
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (01): : 64 - 69
  • [3] The Benefit of Early and Frequent Antitumor Necrosis Factor-Alpha Trough Level Determination in Very Early-Onset Inflammatory Bowel Disease
    Gillmore, Taylor
    Jimenez-Rivera, Carolina
    Mack, David R.
    ACG CASE REPORTS JOURNAL, 2023, 10 (11)
  • [4] Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease
    Collen, Lauren, V
    Mitsialis, Vanessa
    Kim, David Y.
    Bresnahan, Mairead
    Yang, Jessica
    Tuthill, Margaret
    Combs, Abigail
    Barends, Jared
    Field, Michael
    Liu, Enju
    Bearup, Richelle
    Okoroafor, Ibeawuchi
    Klein, Christoph
    Muise, Aleixo M.
    Bousvaros, Athos
    Ouahed, Jodie
    Snapper, Scott B.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (09) : 1443 - 1453
  • [5] Very early onset inflammatory bowel disease
    Moran, Christopher J.
    SEMINARS IN PEDIATRIC SURGERY, 2017, 26 (06) : 356 - 359
  • [6] Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
    Al Sulais, Eman
    AlAmeel, Turki
    BIOLOGICS-TARGETS & THERAPY, 2020, 14 : 1 - 11
  • [7] Antitumor necrosis factor treatment for pediatric inflammatory bowel disease
    de Bie, Charlotte I.
    Escher, Johanna C.
    de Ridder, Lissy
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (05) : 985 - 1002
  • [8] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Jansson-Knodell, Claire L.
    Harris, Courtney E.
    Loftus, Edward V., Jr.
    Walker, Randall C.
    Enzler, Mark J.
    Virk, Abinash
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 190 - 198
  • [9] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Claire L. Jansson-Knodell
    Courtney E. Harris
    Edward V. Loftus
    Randall C. Walker
    Mark J. Enzler
    Abinash Virk
    Digestive Diseases and Sciences, 2021, 66 : 190 - 198
  • [10] TREATMENT OF INFLAMMATORY BOWEL-DISEASE USING ANTITUMOR NECROSIS FACTOR-ALPHA ANTIBODY
    WATKINS, PE
    FOULKES, R
    STEPHENS, S
    WARD, P
    WARREN, BF
    BRITISH JOURNAL OF SURGERY, 1995, 82 (05) : 693 - 694
12345